This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Iron Supplementation of Lead-Exposed Infants

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2006 by Cornell University.
Recruitment status was:  Not yet recruiting
Thrasher Research Fund
Information provided by:
Cornell University Identifier:
First received: September 8, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months of age.

Condition Intervention Phase
Lead Toxicity Drug: Ferrous sulfate Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: Pilot Study to Determine the Efficacy of Iron Supplementation in Preventing the Elevation of Blood Lead Concentrations in Young Children

Resource links provided by NLM:

Further study details as provided by Cornell University:

Primary Outcome Measures:
  • Incidence of blood lead concentrations > 10 mcg/dL
  • Mean hemoglobin concentration
  • Mean zinc protoporphyrin concentration

Secondary Outcome Measures:
  • Anthropometry
  • Oxidative stress

Estimated Enrollment: 50
Study Start Date: October 2006

Ages Eligible for Study:   6 Months to 9 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Infants included if gestational age >36 weeks, birth weight > 2500g, no chronic illness, blood lead concentration <10 mcg/dL, hemoglobin >9 g/dL, zinc protoporphyrin >90 mmol/mol heme
  • Mothers included if 18 years or older
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00374790

Contact: Katarzyna Kordas, PhD 607-273-4449

Clinic for Environmnetal Contaminants Not yet recruiting
Montevideo, Uruguay
Principal Investigator: Elena Queirolo, MD         
Sponsors and Collaborators
Cornell University
Thrasher Research Fund
Principal Investigator: Katarzyna Kordas, PhD Cornell University
Study Chair: Rebecca J Stoltzfus, PhD Cornell University
  More Information Identifier: NCT00374790     History of Changes
Other Study ID Numbers: 0604015
Study First Received: September 8, 2006
Last Updated: September 8, 2006

Keywords provided by Cornell University:
Lead toxicity processed this record on August 21, 2017